inhibiting apoptosis
apoptosis resistance
HSPCs
ApoptoMDS
apoptotic susceptibility
Hematopoietic stem cell Apoptosis
phenotypes of congenital bone marrow failure
Checkpoint activation
delays AML evolution
risk of AML evolution
dilemma of checkpoint abrogation
MyeloDysplastic Syndromes
early MDS
presence of functional checkpoint
kinetics of disease progression
impact of apoptotic deregulation
main apoptotic players
stage MDS
pathogenesis
patient-derived samples
activated DNA damage checkpoint
influences malignant transformation kinetics
syndrome phenotypes
hematological symptoms
hematological phenotype
HSPC function
HSPC hypersusceptibility
large collection of patient
engineered mouse models
competitive disadvantage
way
Friend
severe symptomatic period
novel therapeutic approaches
progenitor cells
high selective pressure
acute myeloid leukemia
patients
mechanism
levels
regulators
foe
xenotransplanted mice